Renaissance Technologies’s Compass Therapeutics CMPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-79,000
Closed -$277K 3299
2025
Q3
$277K Sell
79,000
-145,600
-65% -$460K ﹤0.01% 3033
2025
Q2
$584K Sell
224,600
-96,900
-30% -$200K ﹤0.01% 2759
2025
Q1
$611K Buy
321,500
+42,900
+15% +$114K ﹤0.01% 2659
2024
Q4
$404K Buy
278,600
+56,000
+25% +$93K ﹤0.01% 2947
2024
Q3
$410K Buy
222,600
+82,000
+58% +$102K ﹤0.01% 2865
2024
Q2
$141K Buy
140,600
+70,200
+100% +$103K ﹤0.01% 3119
2024
Q1
$139K Sell
70,400
-106,399
-60% -$184K ﹤0.01% 3302
2023
Q4
$276K Buy
176,799
+149,999
+560% +$260K ﹤0.01% 3016
2023
Q3
$53K Buy
+26,800
New +$66.3K ﹤0.01% 3392
2023
Q2
Sell
-52,300
Closed -$171K 3958
2023
Q1
$171K Buy
52,300
+400
+0.8% +$1.57K ﹤0.01% 3336
2022
Q4
$261K Sell
51,900
-12,315
-19% -$49.1K ﹤0.01% 3291
2022
Q3
$146K Sell
64,215
-1,950
-3% -$5.4K ﹤0.01% 3487
2022
Q2
$175K Buy
66,165
+52,865
+397% +$115K ﹤0.01% 3697
2022
Q1
$18K Buy
+13,300
New +$27.5K ﹤0.01% 4011

Other funds holding CMPX